GLP-1 Telehealth in 2026: How to Choose From 20+ Online Programs

A reader emailed us a spreadsheet last month. Nineteen tabs, one per GLP-1 telehealth program, with columns for price, medication type, and a “vibes” rating. She’d been researching for three weeks and was more confused than when she started. That’s not her fault. There are now well over 20 GLP-1 telehealth programs advertising to Americans, they all use nearly identical photos of smiling people in kitchens, and their pricing structures are just different enough that comparing them feels like doing taxes. This isn’t another ranked list — we have full reviews for that. It’s the framework we wish she’d had on day one: five questions that sort the field fast.

Question 1: Flat pricing or escalating?

This is the single biggest source of sticker shock, so start here. GLP-1 dosing steps up over the first several months — semaglutide typically titrates from 0.25 mg toward 1 mg or beyond — and many programs charge more at each dose tier. A plan that starts at $199 can quietly become $350 by month five. Nothing dishonest about it, but you need the month-six number, not the month-one number.

Flat-price programs kill that ambiguity. Lttl charges $129 a month for compounded semaglutide and $199 for tirzepatide at any dose, no contract. CoreAge Rx goes lower still — $99 for tirzepatide, $149 for semaglutide, locked as doses rise — though we flagged in our review that pricing that aggressive from a newer company deserves a wait-and-see attitude. Sprout Health takes the same dose-locked approach at $249 for semaglutide and $299 for tirzepatide, and its math starts winning around the time other programs’ escalators kick in.

The question to ask any program: “What will I pay per month once I’m on a maintenance dose?” If the answer takes more than one sentence, that tells you something too.

Question 2: How much support do you actually want?

Programs split into two philosophies. Bare-bones access: a prescriber reviews you, medication ships, you check in periodically. Cheaper, and honestly fine for self-directed people. Trimi sits here — affordable, smooth onboarding, light coaching by design.

The coached model costs more and asks more of you. Oak builds its whole program around habit change, treating the medication as a catalyst rather than the solution — a stance the research supports, since weight regain after stopping GLP-1s is well documented in the trial literature. But a coaching program you ignore is the most expensive kind of bare-bones access there is. Buy the support level you’ll use, not the one that sounds virtuous at checkout.

Question 3: Brand-name or compounded?

Almost every affordable GLP-1 telehealth program ships compounded semaglutide or tirzepatide — custom-prepared versions from compounding pharmacies. The price gap is enormous: brand-name Wegovy and Zepbound carry list prices north of $1,000 a month without insurance, while compounded programs run roughly $99 to $299.

Say the caveat out loud, because good programs do: compounded GLP-1s are not FDA-approved. The FDA has never reviewed those specific formulations for safety or effectiveness, and the agency has warned about dosing errors with some compounded versions. Also — and this matters — whether any GLP-1 is appropriate for you is the prescriber’s call, not yours and not an ad’s. A program whose provider never pushes back on anything isn’t giving you medical care, it’s giving you fulfillment logistics. With roughly 40% of American adults meeting the clinical definition of obesity per CDC survey data, there are plenty of legitimate candidates. There are also plenty of people for whom the honest answer is no.

Question 4: What happens to your money if it doesn’t work out?

Read refund terms before you’re emotionally committed. The range is wide. HealthRX charges nothing if its providers don’t approve you — you only pay once treatment is actually happening, and approval turnaround is one of its selling points. Others charge a consult fee regardless. Some lock you into multi-month commitments; Lttl and Sprout don’t. And a few will refund unopened medication while most won’t, since shipped medication generally can’t be restocked. None of these policies are secrets, but they live in FAQ pages nobody reads until they’re annoyed.

Question 5: Does the program pass the smell test?

A quick filter that eliminates a surprising number of the 20+ options:

• A licensed prescriber can say no. “Guaranteed approval” means no one’s evaluating you.
• The pharmacy is identifiable. You should be able to find out where the medication comes from.
• Steady-state pricing is public. Not just the intro rate.
• No countdown timers. Prescription medication with a flash-sale widget is a walking red flag.
• State availability is listed. Sprout, for instance, excludes six states — legitimate programs are upfront about this.

Matching the framework to a starting point

If you are…	Prioritize	Worth a look
Budget-first, self-directed	Flat price, low entry	Trimi, Lttl
Worried about creeping costs	Dose-locked pricing	CoreAge Rx, Sprout Health
Focused on keeping weight off	Habit coaching	Oak
Wanting a fast, low-risk start	Pay-only-if-approved	HealthRX
In it for the long haul	Sustainable long-term pricing	Yucca Health

Those links go to our full reviews, which cover the details a table can’t. If you’re weighing compounded programs against brand-name medication specifically, our Oak vs brand-name GLP-1 comparison walks through that exact decision.

Common questions about choosing GLP-1 telehealth

Why do prices vary so much between GLP-1 telehealth programs?

Different pharmacies, different overhead, different bets on customer lifetime. A $99 program and a $299 program may source similar compounded medication — the delta is usually support, brand, and pricing strategy. Cheapest isn’t automatically worst, and expensive isn’t automatically coached.

Is compounded semaglutide safe?

It’s legal when prepared by properly licensed pharmacies, and huge numbers of people use it. But it isn’t FDA-approved, quality depends on the specific pharmacy, and the FDA has documented dosing-error reports with some compounded products. That’s the honest risk profile. A program that pretends there’s no tradeoff is doing marketing, not medicine.

Can I switch programs mid-treatment?

Usually, yes — especially between no-contract programs. You’ll redo intake with the new provider and should be straight with them about your current dose so you don’t restart titration unnecessarily. Avoid gaps between subscriptions; running out mid-switch is the common mistake.

Will insurance cover any of this?

Compounded programs are almost always cash-pay. Brand-name coverage varies wildly by plan and diagnosis, and prior-authorization fights are common. Ironically, that unpredictability is a big reason flat-price telehealth took off in the first place.

Twenty-plus programs sounds overwhelming until you apply these five questions, at which point most of the field eliminates itself. Steady-state price, support you’ll use, eyes-open on compounding, fair exit terms, and a prescriber who acts like one. Get those right and the remaining choice is mostly taste.

Related resource: our GLP-1 Telehealth Price Index puts the current starting prices of nine programs side by side, updated as the market moves.